University Of Rome Tor Vergata
Clinical trials sponsored by University Of Rome Tor Vergata, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a chatbot keep dialysis patients on track between sessions? Results expected Nov 2026 (estimated)
- Can a PET scan predict if immunotherapy works? new study aims to find out Results expected Dec 2026 (estimated)
- Can Team-Based learning help nurses better manage Children's pain? Results expected Apr 2027 (estimated)
-
Can a simple mesh stop hernias after emergency surgery?
Prevention Not yet recruitingThis trial tests whether placing a special mesh during emergency abdominal surgery can prevent incisional hernias, a common complication. Adults undergoing emergency midline laparotomy will be randomly assigned to receive either the mesh reinforcement or standard suture closure. …
Sponsor: University of Rome Tor Vergata • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Can a chatbot keep dialysis patients on track between sessions?
Symptom relief Not yet recruitingPeople on hemodialysis must closely manage fluid, diet, and their vascular access between sessions, and sticking to these routines is hard. Researchers at the University of Rome Tor Vergata built DialysisBot, an AI chatbot that answers patient questions using only a hospital-appr…
Sponsor: University of Rome Tor Vergata • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can Team-Based learning help nurses better manage Children's pain?
Knowledge-focused Not yet recruitingThis trial investigates whether a cooperative learning technique called the Jigsaw method can boost nursing students' knowledge and attitudes about managing pain in children. About 150 third-year nursing students from two Italian universities will be randomly assigned to either J…
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
New study aims to unlock secrets of hepatitis d treatment success
Knowledge-focused Not yet recruitingThis observational study looks at data and samples from 220 people with hepatitis D (HDV) who are already taking the medication bulevirtide. Researchers want to see how well the drug works over time and find markers that predict a good response. The goal is to improve monitoring …
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New blood tests could sharpen CMV monitoring in transplant patients
Knowledge-focused Not yet recruitingThis study looks at whether measuring two new viral markers (CMV-RNA and TTV-DNA) in the blood can give a clearer picture of CMV infection in patients who have had a stem cell transplant and are taking the drug letermovir to prevent CMV. Researchers will track 290 adult transplan…
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC